(A) A schematic diagram of the FERM, PDZ, and catalytic domain (PTPase) of PTPN4. The targeting construct was designed with a loxP site between exon 20 and 21 followed by loxP sites flanking the neomycin cassette. Probe 7 was used in Southern blot analysis to detect the targeted locus and the KO locus. B, Bam HI; E, Eco RI; X, Xba I; neo, neomycin cassette. (B) Two ES cell clones (left panel: control, 3F5; positive for the targeted allele, 3F6) and F1 progeny from B6 crosses (right panel: lanes 1–3) were analyzed by Southern blotting to confirm the presence of the flanking loxP (floxed) targeted allele. Progeny from MORE-Cre crosses were examined for recombination of the floxed allele (wild type mice, +/+; heterozygotes, +/−; knock-out mice, −/−). Genomic DNA was digested with XbaI and hybridized with radiolabelled probe 7. Wild type (WT), targeted (flox), and recombined alleles are indicated. (C) To detect recombination of the targeted allele in mice, DNA was purified from either the tail or thymus of WT and PTPN4-deficient mice and amplified with PCR primers. (D) PTPN4 mRNA from the thymus of WT and PTPN4 knockout mice was amplified using RT-PCR for the full-length and the catalytic regions of PTPN4. (E) Equivalent amounts of messenger RNA, isolated from the thymus (T), spleen (S), and testes (Te) of WT (lanes 1–3) and PTPN4 knockout mice (lanes 4–6) were reversed transcribed into cDNA using primers for PTPN4 (upper panel, 2.7 kb) or GAPDH (lower panel, 0.3 kb). No product was detected when the reverse transcriptase was excluded from the reaction (lane 7).